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Abstract An antimicrobial substance produced by the
Paenibacillus alvei strain AN5 was detected in fermenta-
tion broth. Subsequently, cell-free culture supernatant
(CFCS) was obtained by medium centrifugation and fil-
tration, and its antimicrobial activity was tested. This
showed a broad inhibitory spectrum against both Gram-
positive and -negative bacterial strains. The CFCS was then
purified and subjected to SDS-PAGE and infrared spec-
troscopy, which indicated the proteinaceous nature of the
antimicrobial compound. Some de novo sequencing using
an automatic Q-TOF premier system determined the amino
acid sequence of the purified antimicrobial peptide as Y-S-
K-S-L-P-L-S-V-L-N-P (1,316 Da). The novel peptide was
designated as peptide AN5-1. Its mode of action was
bactericidal, inducing cell lysis in E. coli ATCC 29522 and
S. aureus, and non-cell lysis in both S. marcescens and B.
cereus ATCC 14579. Peptide AN5-1 displayed stability at
a wide range of pH values (2–12) and remained active after
exposure to high temperatures (100 C). It also maintained
its antimicrobial activity after incubation with chemicals
such as SDS, urea and EDTA.
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Introduction
Due to the increasing numbers of resistant pathogenic
bacteria and side effects caused by existing antibiotics, new
antimicrobial compounds with effective properties are
needed [9]. Antimicrobial peptides are attracting increasing
interest as a potential substitute. The importance of anti-
microbial peptides has been appreciated in the last 20 years
due to pathogenic bacterial resistance against existing
antibiotics [24].
Antimicrobial peptides are small proteins occurring in
living organisms and are produced as defense molecules
against pathogens such as bacteria. Therefore, it is con-
sidered the first line of defense in invaded eukaryotic and
prokaryotic cells [24]. Their mode of action varies between
peptides. Three factors play a major role in determining the
mode of action: the net positive charge on the surface, its
3-D amphipathic structure and the selective disruption
points on the target cell membrane [17]. These actions
were studied by Hallock et al. [10] based on solid-state
NMR, which showed an interaction between antimicrobial
peptides and membranes, leading to membrane disruption.
However, in terms of medical and food applications, anti-
microbial peptides have no toxic effects on mammalian
cells [20], making them a promising candidate for further
studies.
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In 1925, the first antimicrobial peptide was discovered
from Gram-negative bacteria, Escherichia coli, known
ascolicins. This was followed by the discovery of nisin in
1928, which was an antimicrobial peptide produced by the
Gram-positive Streptococcus lactis (formerly known as
Lactococcus lactis) [12]. Since then, several Gram-positive
bacteria, in particular soil bacteria bacilli, have been
reported to produce antimicrobial agents such as bacitracin,
lichenin and cerein, which are produced by Bacillus sub-
tilis, Bacillus licheniformis and Bacillus cereus, respec-
tively [7, 19, 23]. Production of antimicrobial peptides
is considered an unstable bacterial characteristic because
it changes according to growth conditions. A tradeoff
between metabolism and gene expression affects antimi-
crobial peptide biosynthesis during bacterial growth [26].
Paenibacillus alvei are Gram-positive, rod-shaped,
motile, spore-forming and catalase-positive bacteria [22].
The first report of antimicrobial peptide production from
this bacteria was by Anandaraj et al. [1], who isolated a
strain from fermented tomato fruit and detected two anti-
microbial peptides, Paenibacillin P and Paenibacillin N.
Other species of Paenibacillus have been reported as
antimicrobial peptide producers too. For example, poly-
myxins, LI-F complex, saltavalin and gatavalin are pro-
duced by different strains of Paenibacillus polymyxa [25].
This study aimed to isolate an antimicrobial peptide from
the cell-free culture supernatant (CFCS) of P. alvei AN5,
screen its antimicrobial activity and identify the amino acid
sequence of the antimicrobial peptide.
Materials and methods
Microorganisms
Paenibacillus alvei AN5 with a 16S rRNA gene accession
number of JQ868768 at GenBank was obtained from the
Biochemical Engineering Laboratory, Faculty of Engi-
neering and Built Environment, Universiti Kebangsaan
Malaysia. It was grown in nutrient broth (NB) (Oxoid
limited, UK) at 30 C, under agitation at 150 rpm for 24 h.
The test strains used in this study (Table 1) were obtained
from the American Type Culture Collection (ATCC) and
Biochemical Engineering Laboratory, Faculty of Engi-
neering and Built Environment, UKM. All bacterial strains
were grown in tryptic soy broth (TSB) (Difco, France) and
NB at 37 C, under agitation at 150 rpm for 24 h.
Production of the antimicrobial compound
Paenibacillus alvei AN5 was grown in NB at 30 C for
24 h. The resulting culture was used to inoculate a 2 l flask
containing 500 ml of modified Landy medium consisting
of 20 g l-1 glucose, 2 g l-1 yeast extract, 5.0 g l-1
L-glutamic acid, 2 g l-1 KH2PO4, 0.16 mg l
-1 CuSO4,
0.5 g l-1 MgSO47H2O, 0.15 mg l-1 FeSO4, 0.5 g l-1
KCl, 4 g l-1 NaCl, 1 g l-1 (NH4)NO2, 1 g l
-1 NH4SO4
and 45.0 mg l-1 MnSO4H2O, pH 7. The sample was
incubated at 30 C, under agitation at 150 rpm for 24 h.
The CFCS was obtained at 2-h intervals by culture cen-
trifugation at 9,000 rpm for 20 min followed by 0.22-lm
membrane filtration. The CFCS was heated up to 65 C for
20 min for protease inactivation. The antimicrobial sub-
stance production during the P. alvei AN5 growth cycle
was determined by measuring total activity in arbitrary
units (AU), defined as the reciprocal of the highest dilution
of CFCS yielding clear inhibition zones against the indi-
cator microorganism [19]. In this study, Escherichia coli
ATCC 29522 was used as the indicator strain during
purification and characterization of the antimicrobial
compound.
Table 1 Antimicrobial activity of cell free culture supernatant
(CFCS) from P. alvei AN5 and the MICs of the synthesized antimi-
crobial peptide AN5-1 against test strains





















Bacillus anthracis ? 128
Bacillus licheniformis ? [128









Pseudomonas aeruginosa – –
Enterobacter spp. ??? 16
Serratia marcescensa ???? 32
–, no inhibition zones; ?, zone diameter 1–11 mm; ??, zone
diameter 12–16 mm; ???, zone diameter 16–21 mm. ???? zone
diameter C22 mm
a Test strains are incubated in NA
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Determination of antimicrobial activity
Antimicrobial activity was assessed by agar well diffusion
assays as described [6] with some modifications. Briefly,
100 ll of each test strain (OD600 = 0.1) was mixed with
20 ml of TSA or NA before being solidified and cast in a
Petri dish. A total of three circular wells were cut with
diameters of 6 mm and filled with 100 ll of CFCS
obtained after 20 h of cultivation. Plates were incubated at
4 C for 8 h to allow absorption and were further incubated
at 37 C for 24 h. Tests were carried out in triplicate and
averages of inhibition zones were reported.
Purification of the antimicrobial compound
Cell-free culture supernatant was subjected to ultra-filtra-
tion using 5, 10 and 30 kDa molecular weight cut-offs
(MWCO) (Sigma Aldrich, Germany). Four fractions were
obtained and tested against the indicator strain. The CFCS
was then subjected to ascending ammonium sulfate satu-
ration at 50, 60, 70 and 80 %. Pellets were obtained by
centrifugation at 9,000 rpm and were resuspended in 10 ml
of phosphate buffered saline (PBS), pH 7.2. The active
fraction with the lowest saturated percentage was subjected
to manual column cation exchange chromatography using
SP-Sepharose fast flow (Sigma Aldrich, Sweden); equili-
bration was carried out using 5 mM of ammonium acetate
at pH 5. The sample was fractionated using the same buffer
with a linear gradient derived from 50 to 1,150 mM NaCl
at 100-mM intervals. The active fraction was then further
purified using gel filtration chromatography Sephadex
G-25 fine (Sigma Aldrich, Germany) and eluted with buffer
containing 50 mM sodium phosphate and 150 mM NaCl at
pH 7.0. Fractions were collected, concentrated using a
freeze dryer and then tested for antimicrobial activity
against the indicator strain. The total activity of the purified
active fraction was determined by measuring the total
activity as described previously [19]. The molecular weight
and sample purity were checked using 16.5 % tricine SDS-
PAGE as described by Scha¨gger [27, 28]. The gel was cut
into vertical parts and one half of the gel was stained with
coomassie blue R-250, while the other was overlaid on
(0.7 %) soft NA containing fresh overnight culture of the
indicator strain, as described [2].
Infrared spectroscopy (IR) of the antimicrobial peptide
Purified antimicrobial peptide was lyophilized and sub-
jected to Fourier transform infrared (FT-IR) spectroscopy
(Thermo scientific NICOLET 6700, Japan) in order to
determine the functional groups and chemical bonds.
Identification of the antimicrobial peptide
The purified sample was further analyzed by integrated
nano liquid chromatography electrospray ionization mass
spectroscopy (LC/ESI–MS) (Waters, UK). Nano ultra
performance liquid chromatography (UPLC) separation
was performed with a nano ACQUITY@ UPLC system,
equipped with a Symmetry C18 5 lm, 20 mm 9 180 lm
pre-column and BEH C18 1.7 lm, 20 cm 9 75 lm, ana-
lytical reversed-phase column. Following the manufac-
turer’s instructions, 500 ng of sample was initially loaded
and transferred with 0.1 % of aqueous formic acid solution
to the pre-column at a 15 ll min-1 flow rate for 3 min. The
mobile phase consisted of 0.1 % formic acid in water
(Solvent A) and 0.1 % formic acid in acetonitrile (Solvent
B). The sample was separated with a gradient of 1–40 % of
solvent B in solvent A for 90 min at a flow rate of
3 ll min-1, followed by a 3-min rinse with 85 % of sol-
vent B in solvent A. The column was re-equilibrated to the
initial conditions for 20 min. The total cycle time from
injection to injection was 120 min. The eluted sample was
directly exposed to positive electrospray ionization per-
formed using capillary and cone voltages at 3 kV and
20 V, while the source temperature was maintained at
80 C. Collision energies were set at 4 V and 15–40 V for
both MS and MS/MS. De novo peptide sequencing was
performed by data directed analysis (DDA), where the only
input required was the intensity threshold to trigger MS/MS
acquisition and the MS/MS acquisition time. During the
course of MS/MS acquisition, the collision energy was
ramped up with a pre-defined collision energy profile,
maximizing data quality and information while minimizing
user input and the time required. Deisotoping and database
searching of the fragmented spectra was automatically
performed using the Q-TOF premier system and Protein-
Lynx Global SERVER v 2.4 software.
Synthesis of the antimicrobial peptide and minimum
inhibitory concentrations (MICs)
The resulting amino acid sequence was sent for peptide
synthesis service at Firstbase Laboratories Sdn. Bhd.,
Malaysia. The obtained peptide was then tested for anti-
microbial activity against E. coli ATCC 29522. The min-
imum inhibitory concentrations (MICs) were determined
according to the National Committee for Clinical Labora-
tory Standards (NCCLS). The concentrations of the syn-
thesized antimicrobial peptide AN5-1 ranged from 0.25 to
128 lg ml-1. The lowest concentration yielding a clear
inhibition zone was reported as the MIC for each test
strain.
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Mode of antimicrobial peptide action
Mode of action was screened against four selected test
strains: S. marcescens, E. coli ATCC 29522, S. aureus and
B. cereus ATCC 14579. They were grown in 10 ml of
TSB, and the purified antimicrobial peptide at total activity
of 80 AU ml-1 was added during the early exponential
phase. Changes in turbidity at 600 nm were measured at
1-h intervals and compared with control test strains grown
in TSB without antimicrobial peptide [15]. The selected
test strains were harvested after incubation with peptide
AN5-1, re-cultivated on fresh NA and the growth activity
was detected. The inhibitory activity (I.A.) of ACE was
measured as follows [21]:
I:A: ¼ 100  100  OD 600 að Þ
OD 600 bð Þ ;
where (a) is culture containing antimicrobial peptide AN5-
1 and (b) control without the antimicrobial peptide AN5-1.
Stability of the antimicrobial peptide
The stability of the purified antimicrobial peptide (80
AU ml-1) was determined by exposing it to different
ranges of temperature, pH values and chemicals. For
temperature stability measurements, the sample was
exposed to various temperatures (40–110 C at intervals
of 10 C) for over 30 min. For pH stability, the samples
were incubated at various pH values (2–13 at intervals of
1.0 pH unit) using 0.5N NaOH and 0.5N HCl, followed
by 2 h of incubation at 25 C and then neutralized to
their original pH prior to testing antimicrobial activity
[5]. Chemical effects were evaluated by incubating the
sample with 1 % SDS (w/v), 10 mM EDTA (Vivantis,
Malaysia) and 1 % urea (w/v) (Sigma Aldrich, USA) for
1 h at 37 C, followed by centrifugation at 10,000 rpm
for 5 min. The supernatants were tested for antimicrobial
activities [15].
Results
Antimicrobial compound production during growth
cycle
Figure 1 shows the relationship between P. alvei AN5
growth and antimicrobial compound production in modified
Landy medium. Antimicrobial compound production star-
ted in the middle of the exponential phase, where it reached
the highest levels of 80 AU ml-1 during the early stationary
phase. There was no decline in the antimicrobial compound
production levels within 24 h of cultivation.
Screening of the antimicrobial activity
Cell Free Culture Supernatant (80 AU ml-1) obtained after
20 h of cultivation inhibited the growth of Staphylococcus
aureus, Lactobacillus plantarum ATCC 8014, Lactococcus
lactis ATCC 11454, Bacillus subtilis, B. cereus ATCC
14579, Bacillus anthracis, B. licheniformis, Bacillus flexus,
E. coli ATCC 25922, Salmonella enteritidis ATCC 13076
and Serratia marcescens. However, there was no activity
observed against Pseudomonas aeruginosa, Streptococcus
agalactiae ATCC 12386, Staphylococcus epidermidis and
Methicillin Resistance Staphylococcus aureus, MRSA
(Table 1).
Identification of the antimicrobial peptide
Cell Free Culture Supernatant was fractionated using 30-,
10- and 5-kDa (MWCO) filters. Supernatant obtained
below 5 kDa was the only active fraction against the
indicator strain. The CFCS was subjected to ascending
ammonium sulfate precipitation from 50 to 80 % in 10-unit
intervals. The lowest active saturated percentage was
70 %, which was further purified using SP-Sepharose fast
flow. The active fraction was eluted with 750 mM of NaCl
in 5 mM ammonium acetate and was further purified using
gel filtration chromatography, resulting in six fractions
where only the first elution was active against the indicator
strain. The purity of the sample was checked using Tricine
SDS-PAGE, where a single band with a molecular mass
estimated to be *1.5 kDa was observed. This band
showed antimicrobial activity on soft agar against E. coli
ATCC 29522 (Fig. 2). The purified antimicrobial com-
pound was lyophilized and subjected to FT-IR, which
showed major peaks at 3,393.3, 1,645.2 and 1,408.7 cm-1
(Fig. 3). Both the FT-IR and SDS-PAGE findings demon-




















Fig. 1 Profile of Paenibacillus alvei AN5 growth and antimicrobial
peptide production in Modified Landy Medium at 30 C, 150 rpm in
2 h intervals, absorbance at 600 nm (filled circle), and antimicrobial
peptide production (AU ml-1) determined by micro-dilution assay
(filled square)
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compound found in CFCS. The purified antimicrobial
peptide was further analyzed using LC–ESI/TOF–MS.
The MS analysis indicated the presence of a peptide
1,316.7340 Da in size (Fig. 4a). The TOF–MS/MS spec-
trum consisted of a series of y and b ions with several ion
fragments. Molecular weight subtractions for the resulting
m/z values were automatically performed. The amino acid
sequence was deducted by interpreting the ESI–MS/MS
spectra displaying the fragments of m/z 116.1 (y1), m/z
136.1 (a1), m/z 230.1 (y2), m/z 251.1 (b2), m/z 343.2 (y3),
m/z 379.2 (b3), m/z 442.3 (y4), m/z 466.2 (b4), m/z 529.3
(y5), m/z 579.3 (b5), m/z 676.3 (b6) and m/z 789.4 (b7)
(Fig. 4b), which suggested the amino acid sequence of
AN5-1 to be Y-S-K-S-L-P-L-S-V-L-N-P. The peptide
sequence was then compared with the NCBI and APD
databases, with the results suggesting a novel antimicrobial
peptide that displayed low similarity to existing antimi-
crobial peptides (Table 2). Antimicrobial peptide AN5-1
was registered in UniProt under the accession number
B3EWQ6. In order to verify the antimicrobial activity was
due to the antimicrobial peptide AN5-1, the determined
amino acid sequence was synthesized and further tested for
antimicrobial activity. The purity was checked by the
manufacturer using HPLC, and resulted in[90 % which is
acceptable for biological activity tests according to
the manufacturer’s instructions. The synthesized peptide
AN5-1 was tested against E. coli ATCC 29522, and the
resulting inhibition zones were 17 mm similar to the one
obtained from CFCS, which confirms the active structure
of the small antimicrobial peptide AN5-1.
Characterization and MICs of the antimicrobial peptide
The MICs of the synthesized antimicrobial peptide AN5-1
were assessed against test strains and the resulting MICs
are reported in Table 1. Antimicrobial peptide AN5-1 has
exhibited a strong antimicrobial activity against Gram-
negative bacterial strains of S. enteritidis ATCC 13076
and E. coli ATCC 29522 with MICs values of 4 and
Fig. 2 Tricine SDS-PAGE supplemented with glycerol for purified
antimicrobial peptide AN5-1 produced by Paenibacillus alvei AN5.
Lane 1 color marker ultra-low range (M.W. 1.06–26.6) KDa (Sigma,
USA), lane 2 purified AN5-1 stained with Coomassie blue, lane 3
bacteriocin assay overlying on soft agar shows inhibitory activity of
the active peptide against E. coli ATCC 29522
Fig. 3 Fourier transform infrared (FT-IR) of purified antimicrobial peptide AN5-1
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8 lg ml-1, where B. anthracis, B. licheniformis and L.
lactis ATCC 11454 showed less sensitivity toward AN5-1
with MICs values of 128 and [128 lg ml-1. To deter-
mine the mode of AN5-1 action, four selected strains of S.
marcescens, E. coli ATCC 29522, S. aureus and B. cereus
ATCC 14579 were grown separately in NB and 80 AU
ml-1 of AN5-1 were added after 5 h of cultivation. The
addition of AN5-1 to E. coli ATCC 29522 and S. aureus
led to a rapid decrease in cell density (Fig. 5a, c), ending
with complete growth inhibition. However, both S. mar-
cescens and B. cereus ATCC 14579 showed less sensi-
tivity towards AN5-1, showing only a slight decrease in
cell density or remaining static (Fig. 5b, d). The selected
test strains were collected after incubation with peptide
AN5-1 and re-cultivated on fresh NA, there was no
growth observed confirming the bactericide action rather
than bacteriostatic. The inhibitory activities were
measured at 1-h intervals after AN5-1 addition, where
S. aureus and E. coli ATCC 29522 showed a relatively
higher inhibitory effect (96.07 and 98.05 %) compared to
S. marcescens (71.52 %) and B. cereus ATCC 14579
(72.77 %) (Table 3). The AN5-1 showed stability at dif-
ferent temperatures within the range of 40–90 C using
E. coli ATCC 29522 as the indicator strain. The activity
of AN5-1 declined at 100 C and was completely absent
at 110 C, indicating that the AN5-1 peptide was thermo-
labile. In addition, AN5-1 retained its activity within the
range of pH 2 to 12 and was completely inactivated at pH
1 and 13. The AN5-1 was also not affected by chemicals
such as SDS, urea and EDTA (Table 4). Storage of AN5-
1 at -20 C did not affect the antimicrobial property for
120 days. Storage at 4 and 37 C showed a declining
pattern of antimicrobial property after 85 and 20 days,
respectively.
Fig. 4 Mass spectroscopy of purified antimicrobial peptide AN5-1,
a ESI spectra of purified antimicrobial peptide AN5-1 obtained from
UPLC shows the single band has three charges of molecular mass
439.9275m/z ionized by ESI with overall molecular mass
1,316.7340 Da. b MS/MS spectra of purified antimicrobial peptide
AN5-1 performed automatically using ProteinLynx Global SERVER
v 2.4 software based on Q-TOF premier system
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Discussion
In this study, a novel antimicrobial compound was isolated
from the CFCS of P. alvei AN5 during the early exponential
growth phase. It has been reported that bacterial strains freshly
isolated from their natural habitats contain the gene needed for
antimicrobial peptide production [26]. Under laboratory
conditions, bacterial strains grow as a monoculture with no
microbial competitors and less stress, which make antimi-
crobial peptide production unnecessary in the culture [26].
The antimicrobial compound purified in this study showed a
wide bactericidal inhibitory spectrum against both Gram-
positive and negative strains (Table 1). Purification of CFCS
was carried out in three steps, salting out, cation exchange
chromatography and gel filtration chromatography. The pro-
teinaceous nature of the purified antimicrobial compound was
confirmed by the existence of N–H stretching (amide A) and
C=O stretching (amide I) at 3,393.3 and 1,645.2 cm-1
,respectively [16]. Meanwhile, absorbance at 1,408.7 cm-1
corresponded to the C=O stretching (symmetric) of COO-
[18]. Further analysis using LC–ESI/TOF–MS demonstrated
a molecular weight of 1,316.7340 Da, which was derived
from a triple-charged single ion peak ionized by ESI as the
ionization source (Fig. 4a). Based on the automatic calcula-
tion using data analysis software (PLGS), DDA analysis
suggested that the primary structure of the antimicrobial
peptide AN5-1 was Y-S-K-S-L-P-L-S-V-L-N-P (Fig. 4b).
Table 2 Comparison of antimicrobial peptide AN5-1 with other antimicrobial peptides existing in APD
Peptide or protein Sequence Source Similarity (%) References
AN5-1 YSKSLPLSVLNP P. alvei AN5 – This study
Temporin H LSPNLLKSLL Rana temporaria 38.46 [29]
Temporin-1Cd FLPFLASLLSKVL Rana clamitan 37.5 [11]
Odorranain-A-OA1 VVKCSYRLGSPDSQCN Odorrana andersonii 35.29 [32]
Alyteserin-2b ILGAILPLVSGLLSNKL Odorrana andersonii 35.29 [8]
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Fig. 5 Effects of 80 AU ml-1
of purified antimicrobial peptide
AN5-1 produced by P. alvei
AN5 on early exponential
growth phase against target
strains: a E. coli ATCC 29522,
b S. marcescens, c S. aureus and
d B. cereus ATCC 14579, in the
absence (filled circle) and
presence (filled triangle) of
antimicrobial peptide AN5-1.
The bacterial growth was
measured by means of optical
density at 600 nm (OD600)
Table 3 Inhibitory activities, percentage of antimicrobial peptide
AN5-1 at 80 AU ml-1 against selective target cells
Target cells Inhibitory activities (%)
1 h 2 h 3 h 4 h 5 h
E. coli ATCC 29522 45.71 85.1 97.1 98.05 98.05
S. marcescens 27.1 55.55 69.1 71.5 71.5
S. aureus 55 89.7 96.07 96.07 96.07
B. cereus ATCC 14578 45.02 66.33 71.42 72.77 72.77
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The sequence obtained was matched against the NCBI
swissprot database, resulting in 83 % partial identity with
a putative uncharacterized protein (accession number:
B3EFZ9) isolated from Chlorobium limicola (strain DSM
245/NBRC 103803). To date, protein B3EFZ9 has not been
reported to possess antimicrobial activity. Meanwhile,
comparison with the APD database resulted in 38.46 %
similarity with Temporin H isolated from Rana temporaria
[29], 37.5 % similarity with Temporin-1Cd isolated from
Rana clamitan [11], and only 35.29 % similarity with
Odorranain-A-OA1, Alyteserin-2b and Temporin 1Ja iso-
lated from Odorrana andersonii, the European midwife
toad and Rana japonica, respectively [8, 13, 32].
It has been reported that low molecular mass antimi-
crobial peptides produced by Gram-positive bacteria have
bactericidal action [14]. As previously reported in 2005,
antimicrobial peptides interact with the bacterial outer
membrane and pass through, causing pore formations that
may lead to cell lysis. However, the mechanism of both pore
formation and cell lysis is not well understood and often
based on the metabolic activity of the target cell [3, 17].
Both positive charge and hydrophobic amino acids content
of the antimicrobial peptides play a major role in the
interactions with the negatively charged membrane of
the target cell [30, 31]. In this study, we speculated that the
antimicrobial peptide AN5-1 with a positive charge and
four hydrophobic amino acids residues of one valine
(V) and three leucine (L), was likely to interact with the
target cell membrane, causing pore formations that led to
cell lysis such as E. coli ATCC 29522 and S. aureus
(Fig. 5a, c). On the other hand, the steady OD600 mea-
surements after addition of AN5-1 to both S. marcescens
and B. cereus ATCC 14579 (Fig. 5b, d), were an evidence
of a bactericidal with no cell lysis action, suggesting that the
formed pores led to either damage in the macronutrient
synthesis such as nucleic acids and proteins, or lipid mod-
ifications in the membrane bilayer rather [30]. The high
stability against heat and pH ranges are two major industrial
characteristics of AN5-1 that make it a promising candidate
as a food preservative, compared with nisin, whose maxi-
mum acidic stability reaches a pH value of 2 [4].
Conclusion
In the present study, we purified and characterized a new
antimicrobial peptide (AN5-1) secreted into the cultivation
medium of P. alvei AN5. Peptide AN5-1 showed remark-
able stability over a wide temperature and pH range. The
AN5-1 also displayed a bactericidal broad spectrum of
targets against both Gram-positive and -negative bacteria.
However, further studies are in process in our laboratory
investigating the mechanism of AN5-1 action and target
cell morphological changes.
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